Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
04 October 2024 | Story Dr Nitha Ramnath | Photo Supplied
International Young Scholars Conference 2024
International Young Scholars Conference.

The University of the Free State (UFS) continues to advance its global academic collaborations, as evidenced by the recent keynote address delivered by Prof Hussein Solomon at the prestigious International Young Scholars Conference at Jawaharlal Nehru University on 3 October 2024. In addition to his keynote, Professor Solomon presented a thought-provoking lecture titled "India’s Contribution in Ensuring Africa’s Security" at Jamia Millia Islamia on 4 October 2024, highlighting India’s significant role in the African security landscape.

Throughout his visit to India, Prof Solomon actively participated in multiple conferences at various universities and institutions, reinforcing the importance of academic dialogue between the two regions. His engagements reflect UFS’s unwavering commitment to fostering international knowledge exchange and collaborative partnerships.

A notable outcome of this visit is the pending finalisation of a Memorandum of Understanding (MOU) with Delhi University. This agreement aims to expand the current partnership with Jawaharlal Nehru University from a faculty-level agreement to a comprehensive, institution-wide collaboration across multiple disciplines beyond the humanities. This development will facilitate joint research initiatives, collaborative PhD supervision, and joint funding proposals, marking a significant step forward for both institutions.

Reflecting on the potential of these partnerships, Prof Solomon remarked, “The Indian academic landscape is incredibly dynamic. With India poised to become the world’s largest economy by 2050, strengthening ties with Indian institutions provides the UFS with immense strategic opportunities.”

Prof Solomon’s academic contributions extend beyond administrative agreements. He is co-editing a forthcoming book on BRICS and climate change with Prof Bashabi Gupta from the Department of Geography at Delhi University. This work aligns with the upcoming BRICS Summit in Kazan, Russia, later this month. Moreover, plans are underway for a second volume, as well as a new book focused on feminist decoloniality from African and Asian perspectives, which seeks to amplify marginalised voices in global scholarship.

In line with the UFS’s dedication to expanding its international reach, Prof Solomon continues to build on existing relationships and pursue new collaborations with Indian scholars, particularly within the BRICS and BRICS Plus frameworks. These efforts will enhance academic exchange and research opportunities, further positioning UFS as a key player in global academic discourse.

As UFS broadens its global footprint, such initiatives not only elevate the institution’s reputation but also enrich the academic experiences of its students and researchers, promoting a more interconnected academic landscape. 

News Archive

UFS to monitor the use of ARV-drugs on pregnant women and children
2004-12-08

The University of the Free State (UFS) is to establish a Pharmacovigilance Centre that will monitor the effects of Anti-Retroviral (ARV) drugs on HIV positive pregnant women and children starting early in the new year.

The UFS is one of only two institutions chosen by the Minister of Health, Dr Manto Tshabalala-Msimang, to establish such an ARV monitoring centre.

The other centre will be based at Medical University of South Africa (MEDUNSA) and will concentrate mainly on monitoring the effects of the drugs on adults.

“The establishment of the UFS’s Pharmaconvigilance Centre forms part of government’s Comprehensive Plan on HIV and AIDS, often termed the roll-out plan for ARV drugs. The centre’s primary responsibility will be to specifically monitor the use of these drugs in pregnant women, and children under the age of 13,” said Prof Andrew Walubo of the UFS’s Department of Pharmacology.

“Although most of the side effects of ARV drugs have been identified in other countries, it has now become critical to identify the side effects amongst the South African population. This is important because many people will be exposed to the drugs within a short time. Our aim is so identify the most common side effects and make recommendations for the prevention thereof. The centre will help in detecting the risk of using anti-retroviral drugs in pregnancy and children, and prevention of adverse drug reactions,” said Prof Walubo.

According to Prof Walubo 12 drugs will be monitored – these drugs will be selected according to the patient’s profile.

The centre will comprise of two components: A pregnancy registry, which will focus on a new-born child up until two months and a pediatric registry, which will focus on children who are born of mothers who used ARV drugs and children using ARV drugs.

According to Prof Walubo, the Pharmaconvigilance Centre will also be responsible for offering relevant technical advice, training and selected research on ARV drugs in these patients.

The centre will be fully sponsored by the national Department of Health. It will be based in the UFS’s Faculty of Health Sciences, Department of Pharmacology, and will be run in collaboration with experts from different departments in the faculty.

Media release
Issued by: Lacea Loader
Media Representative
Tel: (051) 401-2584
Cell: 083 645 2454
E-mail: loaderl.stg@mail.uovs.ac.za
8 December 2004

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept